Summary of Research: Apremilast Improves Skin Outcomes in Pediatric Plaque Psoriasis of Shorter Disease Duration: 52-Week Results from the SPROUT Phase 3 Trial.
Saved in:
| Title: | Summary of Research: Apremilast Improves Skin Outcomes in Pediatric Plaque Psoriasis of Shorter Disease Duration: 52-Week Results from the SPROUT Phase 3 Trial. |
|---|---|
| Authors: | Langley, Richard G.1 (AUTHOR) richardgblangley@gmail.com, Arkin, Lisa2 (AUTHOR), Fiorillo, Loretta3 (AUTHOR), Eichenfield, Lawrence F.4,5 (AUTHOR), Lebwohl, Mark6 (AUTHOR), Strober, Bruce7,8 (AUTHOR), Sticherling, Michael9,10 (AUTHOR), Swanson, Lisa11 (AUTHOR), Kokolakis, Georgios12 (AUTHOR), Chaudhari, Siddharth13 (AUTHOR), Deignan, Cynthia13 (AUTHOR), Zhang, Zuoshun13 (AUTHOR), Paller, Amy S.14 (AUTHOR) |
| Source: | Dermatology & Therapy. May2026, Vol. 16 Issue 5, p2229-2232. 4p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21938210 |
|---|---|
| DOI: | 10.1007/s13555-026-01714-0 |
